These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1012 related articles for article (PubMed ID: 27045225)

  • 1. Vascular endothelial growth factor and diabetic macular edema.
    Lally DR; Shah CP; Heier JS
    Surv Ophthalmol; 2016; 61(6):759-768. PubMed ID: 27045225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation.
    Hirano T; Toriyama Y; Iesato Y; Imai A; Hirabayashi K; Nagaoka T; Takamura Y; Sugimoto M; Murata T
    Jpn J Ophthalmol; 2017 Jan; 61(1):51-60. PubMed ID: 27730425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema.
    Bahrami B; Hong T; Zhu M; Schlub TE; Chang A
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1133-1140. PubMed ID: 28238195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema.
    ; ; Aiello LP; Beck RW; Bressler NM; Browning DJ; Chalam KV; Davis M; Ferris FL; Glassman AR; Maturi RK; Stockdale CR; Topping TM
    Ophthalmology; 2011 Dec; 118(12):e5-14. PubMed ID: 22136692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of photocoagulation in ischemic areas to prevent recurrence of diabetic macular edema after intravitreal bevacizumab injection.
    Takamura Y; Tomomatsu T; Matsumura T; Arimura S; Gozawa M; Takihara Y; Inatani M
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4741-6. PubMed ID: 25028357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical Lessons from Protocol I for the Management of Diabetic Macular Edema.
    Mukkamala L; Bhagat N; Zarbin MA
    Dev Ophthalmol; 2017; 60():91-108. PubMed ID: 28427069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.
    Heier JS; Bressler NM; Avery RL; Bakri SJ; Boyer DS; Brown DM; Dugel PU; Freund KB; Glassman AR; Kim JE; Martin DF; Pollack JS; Regillo CD; Rosenfeld PJ; Schachat AP; Wells JA;
    JAMA Ophthalmol; 2016 Jan; 134(1):95-9. PubMed ID: 26512939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic macular edema: Evidence-based management.
    Browning DJ; Stewart MW; Lee C
    Indian J Ophthalmol; 2018 Dec; 66(12):1736-1750. PubMed ID: 30451174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema: recent clinically relevant findings from DRCR.net Protocol T.
    Cai S; Bressler NM
    Curr Opin Ophthalmol; 2017 Nov; 28(6):636-643. PubMed ID: 28837425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedema.
    Lang GE; Liakopoulos S; Vögeler J; Weiß C; Spital G; Gamulescu MA; Lohmann C; Wiedemann P
    Acta Ophthalmol; 2018 May; 96(3):e377-e385. PubMed ID: 29090846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes in Patients with Diabetic Macular Edema Requiring Cataract Surgery in VISTA and VIVID Studies.
    Moshfeghi AA; Thompson D; Berliner AJ; Saroj N
    Ophthalmol Retina; 2020 May; 4(5):481-485. PubMed ID: 31924543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TREATMENT PATTERNS AND 2-YEAR VISION OUTCOMES WITH BEVACIZUMAB IN DIABETIC MACULAR EDEMA: An Analysis From a Large U.S. Integrated Health Care System.
    Fong DS; Luong TQ; Contreras R; Jimenez JJ; Custis PH; Patel V; Campbell JH
    Retina; 2018 Sep; 38(9):1830-1838. PubMed ID: 28796143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema: A Subanalysis of the RESTORE (Extension) Study.
    Karst SG; Deak GG; Gerendas BS; Waldstein SM; Lammer J; Simader C; Guerin T; Schmidt-Erfurth UM
    JAMA Ophthalmol; 2018 Apr; 136(4):315-321. PubMed ID: 29494727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
    Solaiman KA; Diab MM; Abo-Elenin M
    Retina; 2010; 30(10):1638-45. PubMed ID: 20838357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months.
    Arevalo JF; Lasave AF; Wu L; Diaz-Llopis M; Gallego-Pinazo R; Alezzandrini AA; Berrocal MH;
    Retina; 2013 Feb; 33(2):403-13. PubMed ID: 23222389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic Macular Edema: Traditional and Novel Treatment.
    Tomić M; Vrabec R; Poljičanin T; Ljubić S; Duvnjak L
    Acta Clin Croat; 2017 Mar; 56(1):124-132. PubMed ID: 29120156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
    Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
    Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in retinal arteriolar microvascular structure associate with higher treatment burden in patients with diabetic macular oedema: results from a 12-month prospective clinical trial.
    Blindbaek SL; Peto T; Grauslund J
    Acta Ophthalmol; 2020 Jun; 98(4):353-359. PubMed ID: 31654501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photocoagulation or sham laser in addition to conventional anti-VEGF therapy in macular edema associated with TelCaps due to diabetic macular edema or retinal vein occlusion (TalaDME): a study protocol for a multicentric, French, two-group, non-commercial, active-control, observer-masked, non-inferiority, randomized controlled clinical trial.
    Dupas B; Castro-Farias D; Girmens JF; Eginay A; Couturier A; Villeroy F; Delyfer MN; Creuzot-Garcher C; Giocanti-Auregan A; Béral L; Arndt C; Mesnard C; Vicaut E; Chaumet-Riffaud P; Durand-Zaleski I; Paques M
    Trials; 2024 Apr; 25(1):273. PubMed ID: 38649937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between ranibizumab and aflibercept for macular edema associated with central retinal vein occlusion.
    Saishin Y; Ito Y; Fujikawa M; Sawada T; Ohji M
    Jpn J Ophthalmol; 2017 Jan; 61(1):67-73. PubMed ID: 27660163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.